Thermo Fisher Scientific TMO Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | 13.5%-0.2pp | 13%-0.1pp | 13.1%+0.1pp | 13.4%-0.2pp | 13.7%0.0pp | |
| Return on assets | 6.5%-0.2pp | 6.5%0.0pp | 6.5%+0.2pp | 6.6%+0.1pp | 6.6%+0.3pp | |
| Liquidity | ||||||
| Current ratio | 1.5×-0.2× | 1.9×+0.2× | 1.5×-0.1× | 1.9×+0.2× | 1.8×+0.1× | |
| Quick ratio | 1.2×-0.2× | 1.5×+0.2× | 1.1×-0.1× | 1.5×+0.1× | 1.4×+0.1× | |
| Cash ratio | 0.2×-0.1× | 0.7×+0.3× | 0.1×-0.2× | 0.4×-0.1× | 0.3×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×+0.1× | 0.8×+0.1× | 0.8×0.0× | 0.7×-0.1× | 0.7×-0.1× | |
| Debt-to-assets | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Per Share | ||||||
| Book value per share | $139.23+6.8% | $141.29+9.1% | $134.97+5.8% | $133.63+7.9% | $130.32+9.9% | |
| Valuation | ||||||
| Market capitalization | $182.6B-2.7% | $217.7B+9.4% | $183.15B-22.5% | $152.65B-27.7% | $187.73B-15.4% | |
| Enterprise value | $222.48B+0.9% | $252.21B+9.7% | $220.64B-18.6% | $185.49B-24.2% | $220.56B-14.0% | |
| Price / earnings | 26.7×-2.2× | 32.5×+1.1× | 27.9×-10.5× | 23.2×-10.8× | 28.8×-8.0× | |
| Price / book | 3.5×-0.3× | 4.1×+0.1× | 3.6×-1.2× | 3×-1.4× | 3.8×-1.1× | |
| Free cash flow yield | 3.7%+0.1pp | 2.9%-0.8pp | 3.3%0.0pp | 4%+0.3pp | 3.6%+0.2pp | |
| Earnings yield | 3.8%+0.3pp | 3.1%-0.1pp | 3.6%+1.0pp | 4.3%+1.4pp | 3.5%+0.8pp | |
| Dividend yield | 0.4%0.0pp | 0.3%0.0pp | 0.3%+0.1pp | 0.4%+0.1pp | 0.3%+0.1pp | |
| PEG ratio | 5.2×+1.6× | 5.6×+0.2× | 4.1×-5.7× | 4×0.0× | 3.6×-1,106× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Thermo Fisher Scientific's profit margins?
- Thermo Fisher Scientific (TMO) runs a 58.3% gross margin and a 17.2% operating margin, with a 15.2% net margin.
- Where do Thermo Fisher Scientific's ratios come from?
- Every ratio is computed from Thermo Fisher Scientific's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
